NAROPIN 0.2% ropivacaine hydrochloride 40mg/20mL injection ampoule

Aspen Pharmacare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 88da10bfede03fc5
Product Name: NAROPIN 0.2% ropivacaine hydrochloride 40mg/20mL injection ampoule
Artg Id: 52405
Artg Name: NAROPIN 0.2% ropivacaine hydrochloride 40mg/20mL injection ampoule
Sponsor: Aspen Pharmacare Australia Pty Ltd
Company Detail Path: /organization/aspen-pharmacare-australia-pty-ltd
Artg Date: 1996-01-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/819ae343c6bbcf934f972ef2be97dec9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/3d5a80635b5afe13140a07ec2ccfdc29.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

88da10bfede03fc5

Type

Standard